REQUEST A DEMO
Total
USD $0.00
Search more companies

Asta Co.,Ltd. (South Korea)

Main Activities: Irradiation Apparatus Manufacturing
Full name: Asta Co.,Ltd. Profile Updated: July 27, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Ascend Diagnostics specializes in the development and commercialization of advanced medical diagnostic systems, including next-generation diagnostic systems, platform sampling plate diagnostic software, and a New Generation MALDI-TOF-based diagnostic system (IDSys). The company focuses on the medical diagnostics industry. Target market and revenue information are not available.

Headquarters
11F, 145, Gwanggyo-Ro, Yeongtong-Gu, Suwon-Si, Gyeonggi-Do
Suwon; Gyeonggi;

Contact Details: Purchase the Asta Co.,Ltd. report to view the information.

Website: http://www.astams.com

Basic Information
Total Employees:
Purchase the Asta Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the Asta Co.,Ltd. report to view the information.
Registered Capital:
Purchase the Asta Co.,Ltd. report to view the information.
Financial Auditors:
Purchase the Asta Co.,Ltd. report to view the information.
Incorporation Date:
January 27, 2006
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Ownership Details
Purchase this report to view the information.
26.4%
Purchase this report to view the information.
18.2%
Purchase this report to view the information.
2.2%
Subsidiaries
Asta Us
100%
벳데이터(주)
100%
(주)노스퀘스트
59.71%
Company Performance
Financial values in the chart are available after Asta Co.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
-6.34%
Total operating revenue
-6.04%
Operating profit (EBIT)
2.57%
EBITDA
-64.55%
Net Profit (Loss) for the Period
-0.48%
Total assets
-11.19%
Total equity
-14.68%
Operating Profit Margin (ROS)
-3.35%
Net Profit Margin
-6.1%
Return on Equity (ROE)
-6.88%
Debt to Equity Ratio
10.95%
Quick Ratio
-1.03%
Cash Ratio
-1.56%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?